The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays. Even though Advair’s main patent expired in 2010 and ...

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount.

Mylan CEO Heather Bresch says the EpiPen price increase was necessary but the company will offer a $300 generic option Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything ...

CVS (operating in Hawaii as Longs Drugs) is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment ...

You'd think one scandal would be enough. Mylan, the company that came under fire this summer for systematically raising the price of the EpiPen, is caught up in another drug price scheme.